Patents/Assignees

Kymera Therapeutics, Inc.

33 patents in portfolio

US11932624utility2024
MDM2 Degraders and Uses Thereof
0 cites
US11897882utility2024
Tricyclic Crbn Ligands and Uses Thereof
0 cites
US11857535utility2024
Methods of Treating Mutant Lymphomas
0 cites
US11807636utility2023
IRAK Degraders and Uses Thereof
0 cites
US11779578utility2023
IRAK Degraders and Uses Thereof
0 cites
US11773103utility2023
IRAK4 Degraders and Uses Thereof
0 cites
US11746120utility2023
Stat Degraders and Uses Thereof
0 cites
US11723980utility2023
IRAK Degraders and Uses Thereof
0 cites
US11707457utility2023
IRAK Degraders and Uses Thereof
0 cites
US11685750utility2023
Crystalline Forms of IRAK Degraders
0 cites
US11679109utility2023
SMARCA Degraders and Uses Thereof
0 cites
US11623932utility2023
Protein Degraders and Uses Thereof
0 cites
US11591332utility2023
IRAK Degraders and Uses Thereof
0 cites

← PreviousPage 2 of 2